Latest Developments in Global Deep Partial Thickness Thermal Burns Treatment Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Deep Partial Thickness Thermal Burns Treatment Market

  • Healthcare
  • Mar 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In April 2025, Interim results from a prospective observational study, indicated that Ovine Forestomach Matrix (OFM) facilitated rapid burn healing with minimal pain, good cosmetic outcomes, and high patient satisfaction in treating deep partial-thickness burns. The study, involving 15 patients, highlighted OFM's potential as a cost-effective and patient-friendly single-application approach to burn management, reducing the need for additional interventions
  • In April 2025, Hydrogel Dressings Revolutionizing Burn Care, A review article published in 2025 highlighted the increasing popularity and significant benefits of hydrogel dressings in burn care, especially for chronic burn wounds. These dressings contribute to wound moisture, provide cooling and soothing effects, and aid in autolytic debridement. The review emphasizes their role in wound healing and tissue regeneration, indicating continued innovation in this area of advanced wound care
  • In December 2024, Kerecis, a company known for its pioneering use of sustainably sourced fish skin in medical applications, announced the expansion of its silicone fish-skin combination product range for surgical and trauma wounds with SurgiClose® Silicone. While not exclusively for deep partial-thickness burns, this type of advanced biologic product is often applicable in complex wound care scenarios, including burn reconstruction, demonstrating the continued evolution of tissue regeneration solutions in the broader wound care market
  • In March 2023, Convatec Inc. obtained FDA clearance for its innovative medical device, InnovaBurn, designed for the management of complex surgical wounds and partial-thickness burns. This placental extracellular matrix technology offers advanced solutions for second-degree burns, addressing critical needs in the deep partial-thickness thermal burns treatment market by enhancing wound management capabilities
  • In December 2022, MediWound Ltd. received FDA clearance for NexoBrid, a breakthrough product for treating severe thermal burns in adults. This innovative non-surgical debridement option addresses a crucial need in the market by providing effective and efficient management of severe burn injuries